Private EquityRIA · CRD 305614SEC-Registered

Updated:

fermata

Since 2019, fermata has run the world's first FemTech specialty store, connecting global women's health brands with consumers across Japan.

fermata logo

fermata

Data Science for Growers | Fermata builds AI-powered decision support systems for precise plant monitoring in greenhouses & indoor farms utilizing computer vision analysis.

General information

Firm type

Private Equity

Year founded

2019

AUM

Undisclosed

Location

Region

Asia

Country

Japan

City

Tokyo

Corporate office

Tokyo, Japan

Sector focus

Digital HealthFemTech

Frequently asked questions

How does fermata source the products it sells?

fermata procures directly from international FemTech manufacturers — including Elvie, Saalt, INTIMINA, Lunette, and kegg — securing Japanese distribution rights or consignment arrangements. The firm evaluates products based on clinical validation, brand maturity in Western markets, and compatibility with Japanese consumer preferences. It also operates as a soft-landing partner for overseas FemTech companies entering Japan, managing localization and regulatory steps.

Is fermata a venture capital firm or an operating company?

fermata is structured as an operating company with a specialty e-commerce core, not a fund. It does not take equity in the brands it distributes as a matter of published practice, and no investment vehicle is registered under the fermata name. If the firm has made direct minority investments, those have not been disclosed publicly.

What FemTech categories does fermata cover?

fermata organizes its catalog across the full reproductive lifecycle: menstruation products (menstrual cups, period underwear), fertility monitors and conception support tools, menopause management devices, pelvic-floor trainers, sexual wellness items, and intimate skincare. Its symptom-checker tool and LINE-based consultation funnel customers into specific product pathways based on stated concerns.

How is fermata regulated in Japan?

fermata distributes products that fall into multiple regulatory categories — some classified as medical devices, others as general consumer goods. The firm navigates Japan's Pharmaceuticals and Medical Devices Act (PMD Act) for regulated items by working with overseas brands to secure necessary marketing approvals, though specifics of its licensing relationships are not published.

Does fermata have known competitors in Japan's FemTech distribution space?

At launch in 2019, fermata had no direct Japanese competitor aggregating international FemTech brands as a standalone specialty retailer. General e-commerce platforms and individual brand DTC sites existed, but none operated a curated, education-forward storefront spanning menstruation through menopause. The competitive set has since widened, but fermata's early-mover advantage and brand breadth remain distinguishing.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Tokyo Private Equity profiles